The firm has funded 45 MedTech companies over the past 28 years and has founded, built, and exited several successful European MedTech distribution companies. They partner with exceptional entrepreneurs to introduce breakthrough medical technologies to patients and leverage relationships with over 200 clinical sites and dozens of thought leaders to build value for their portfolio companies. 415 CAPITAL has introduced over 25 breakthrough technologies to market and realized over 20 successful portfolio exits to-date, including Vesper Medical, Intact Vascular, Claret Medical, ReCor Medical, CardiAQ Valve Technologies, Atritech, and CoreValve. The company's investments improve patient outcomes and save lives.